Cart
sales@molnova.com
Linderane
CAS No. 13476-25-0
Linderane( Linderane | )
Catalog No. M17966 CAS No. 13476-25-0
Linderane was characterized as a mechanism-based inactivator of CYP2C9.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 38 | In Stock |
|
| 10MG | 61 | In Stock |
|
| 25MG | 123 | In Stock |
|
| 50MG | 179 | In Stock |
|
| 100MG | 267 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLinderane
-
NoteResearch use only, not for human use.
-
Brief DescriptionLinderane was characterized as a mechanism-based inactivator of CYP2C9.
-
DescriptionLinderane is a cytochrome P450 2C9 inhibitor from Lindera aggregata (Sims).
-
In Vitro——
-
In Vivo——
-
SynonymsLinderane |
-
PathwayOthers
-
TargetOther Targets
-
RecptorCYP2C9
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number13476-25-0
-
Formula Weight260.28
-
Molecular FormulaC15H16O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (384.19 mM)
-
SMILESCC1=CCCC23C(O2)C(C4=C(C1)OC=C4C)OC3=O
-
Chemical Name(10S,10aS,E)-5,9-dimethyl-3,6,10,10a-tetrahydro-2H-10,1a-(epoxymethano)oxireno[2',3':4,5]cyclodeca[1,2-b]furan-12-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
MM 07
Apelin biased agonist; exhibits bias for the G protein pathway. Stimulates endothelial NOS phosphorylation and expression, promotes proliferation, and attenuates apoptosis of human pulmonary arterial endothelial cells in vitro. Shows positive inotropic and vasodilatory effects in vivo and improves cardiac structure and function in a model of pulmonary arterial hypertension.
-
Soraprazan
Soraprazan is a reversible, and fast-acting gastric H+/K+ ATPase inhibitor.
-
γ-Decalactone
γ-Decalactone is a natural compound.
